GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DXS International PLC (AQSE:DXSP) » Definitions » COGS-to-Revenue

DXS International (AQSE:DXSP) COGS-to-Revenue : 0.13 (As of Apr. 2024)


View and export this data going back to 2008. Start your Free Trial

What is DXS International COGS-to-Revenue?

DXS International's Cost of Goods Sold for the six months ended in Apr. 2024 was £0.43 Mil. Its Revenue for the six months ended in Apr. 2024 was £3.31 Mil.

DXS International's COGS to Revenue for the six months ended in Apr. 2024 was 0.13.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DXS International's Gross Margin % for the six months ended in Apr. 2024 was 87.06%.


DXS International COGS-to-Revenue Historical Data

The historical data trend for DXS International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DXS International COGS-to-Revenue Chart

DXS International Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.12 0.13 0.14 0.13

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.12 0.13 0.14 0.13

DXS International COGS-to-Revenue Calculation

DXS International's COGS to Revenue for the fiscal year that ended in Apr. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.428 / 3.308
=0.13

DXS International's COGS to Revenue for the quarter that ended in Apr. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.428 / 3.308
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DXS International  (AQSE:DXSP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DXS International's Gross Margin % for the six months ended in Apr. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.428 / 3.308
=87.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


DXS International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DXS International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DXS International Business Description

Traded in Other Exchanges
N/A
Address
119 St Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support, content, and technology to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its products include CompleteCare, ExpertCare, and MyVytalCare.

DXS International Headlines

No Headlines